Samuel Kareff

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Samuel Kareff

Aug 3, 2024, 06:05 | Blog

Samuel Kareff: I’m starting a new position as Medical Oncology/Hematology at Lynn Cancer Institute

Samuel Kareff, Medical Oncologist and Hematologist at the Lynn Cancer Institute/Center for Hematology-Oncology, shared on LinkedIn:…

Jul 13, 2024, 14:20 | Blog

Samuel Kareff: Pan-tumoral analysis of TROP2 among solid tumors

Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…

Jun 12, 2024, 06:29 | Insight

Neuroendocrine tumors may respond better to an oncolytic virus plus immunotherapy - Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared on X: "Our researchers, first author, Samuel Kareff and senior…

Jun 2, 2024, 22:20 | Insight

Sylvester Cancer study on immunotherapy drug durvalumab shows limited access globally due to cost constraints

Access to Targeted Lung Cancer Drug Is Cost-Prohibitive Globally Many countries with national healthcare systems…

May 25, 2024, 12:21 | Blog

Gilberto Lopes: Sylvester Comprehensive Cancer Center Pre ASCO24 Hem-Onc grand rounds

Gilberto Lopes, Associate director for Global Oncology at the Sylvester Comprehensive Cancer Center at the…

Apr 21, 2024, 11:35 | Insight

Samuel Kareff: Our pan-tumor analysis on the not-so-elusive HRAS mutation in solid tumors

Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…

All: 6 Posts: 1 - 100